using an intact animal model without microcirculatory thrombosis , we studied the effects of sulfinpyrazone on ischemic myocardium in 58 anesthetized dogs divided into three groups : control untreated ( n =24 ) , group 1 ( n = 16 ) , treated daily with 300 mg of sulfinpyrazone for 7 days , and group 2 ( n = 18 ) , treated daily with 300 mg of sulfinpyrazone for 7 days but omitting treatment on day 8 .
C0040053
thrombosis
C0038742
sulfinpyrazone